Abstract

Gynecologic oncology surgeries, while critical for managing and treating various cancers of the female reproductive system, often result in postoperative pain. Historically, opioids have been the primary choice for managing this pain. However, the opioid crisis in recent years has raised concerns about over-prescription and potential addiction. Striking a balance between minimizing opioid use and ensuring adequate pain control is crucial in gynecologic oncology. In this article, we will explore the challenges and strategies for optimizing postoperative opioid prescriptions in this specialized field.